POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SV5_A_65BA600_0 (REVERSE TRANSCRIPTASE)	1xfb	ALDOLASE C (Homo sapiens)	5 / 10	LEU A 210 VAL A 265 VAL A 187 PRO A 295 LEU A 257	None	1.34A	22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SV5_A_65BA600_0 (REVERSE TRANSCRIPTASE)	2jii	SERINE/THREONINE-PRO TEIN KINASE VRK3 MOLECULE: VACCINIA RELATED KINASE 3 (Homo sapiens)	5 / 10	LEU A 381 LYS A 382 VAL A 283 LEU A 428 TYR A 385	None	1.47A	21.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SV5_A_65BA600_0 (REVERSE TRANSCRIPTASE)	5lkz	HISTONE ACETYLTRANSFERASE P300,HISTONE ACETYLTRANSFERASE P300 (Homo sapiens)	5 / 10	LEU A1584 LYS A1583 VAL A1512 LEU A1495 TYR A1585	None	1.33A	22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3M8P_A_65BA562_0 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H P51 RT)	1zrz	PROTEIN KINASE C, IOTA (Homo sapiens)	5 / 11	LEU A 554 VAL A 262 VAL A 250 PHE A 245 LEU A 242	TPO  A 555 ( 4.1A) None None None None	1.48A	20.00 19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3M8P_A_65BA562_0 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H P51 RT)	2csw	UBIQUITIN LIGASE PROTEIN RNF8 (Homo sapiens)	5 / 11	LEU A 108 VAL A  46 VAL A  65 TYR A  48 LEU A  50	None	1.49A	13.62 14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3M8P_A_65BA562_0 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H P51 RT)	2w2x	1-PHOSPHATIDYLINOSIT OL-4,5-BISPHOSPHATE PHOSPHODIESTERASE GAMMA-2 (Homo sapiens)	5 / 11	LEU C  34 VAL C  65 VAL C  91 PHE C 105 TRP C 104	None	1.18A	13.42 14.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3M8P_A_65BA562_0 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H P51 RT)	3a5k	TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 1 (Homo sapiens)	5 / 11	VAL A 108 VAL A 155 TYR A 152 TYR A 176 LEU A 195	None	1.37A	20.76 19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3M8P_A_65BA562_0 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H P51 RT)	3sop	NEURONAL-SPECIFIC SEPTIN-3 (Homo sapiens)	5 / 11	VAL A 205 VAL A 224 TYR A 176 PHE A 177 LEU A  72	None	1.47A	19.50 20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3M8P_A_65BA562_0 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H P51 RT)	4o9r	SMOOTHENED HOMOLOG/SOLUBLE CYTOCHROME B562 CHIMERIC PROTEIN (Escherichia coli; Homo sapiens)	5 / 11	LEU A 367 VAL A 334 VAL A 411 PHE A 360 LEU A 363	None	1.37A	21.55 23.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3M8P_A_65BA562_0 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H P51 RT)	4rh7	GREEN FLUORESCENT PROTEIN/CYTOPLASMIC DYNEIN 2 HEAVY CHAIN 1 (Homo sapiens; synthetic construct)	5 / 11	LEU A1939 LYS A1944 VAL A1946 LEU A1992 GLU A1938	None	1.33A	9.81 8.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3M8P_A_65BA562_0 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H P51 RT)	5c5b	DCC-INTERACTING PROTEIN 13-ALPHA DCC-INTERACTING PROTEIN 13-BETA (Homo sapiens; Homo sapiens)	5 / 11	LEU A  40 TYR A 203 PHE B  89 LEU B  65 TYR A  36	None	1.30A	20.11 22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3M8P_A_65BA562_0 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H P51 RT)	5cmn	LATROPHILIN-3 (Homo sapiens)	5 / 11	LEU E 376 VAL E 355 VAL E 323 TYR E 321 LEU E 389	None	1.22A	17.54 20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	1wsv	AMINOMETHYLTRANSFERA SE (Homo sapiens)	5 / 12	LEU A 348 VAL A 319 VAL A 293 GLY A 335 PRO A 307	LEU  A 348 ( 0.6A) VAL  A 319 ( 0.6A) VAL  A 293 ( 0.6A) GLY  A 335 ( 0.0A) PRO  A 307 ( 1.1A)	1.22A	20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	1xk5	SNURPORTIN-1 (Homo sapiens)	5 / 12	LEU A 115 VAL A 285 VAL A 288 GLY A 287 LEU A 108	None	1.27A	15.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	1ygu	LEUKOCYTE COMMON ANTIGEN (Homo sapiens)	5 / 12	LEU A 879 VAL A 871 TYR A 838 GLY A 833 PRO A 795	None	1.25A	22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	2aex	COPROPORPHYRINOGEN III OXIDASE, MITOCHONDRIAL (Homo sapiens)	5 / 12	LEU A 288 GLY A 333 PHE A 296 TRP A 452 PRO A 255	None	1.19A	20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	2amy	PHOSPHOMANNOMUTASE 2 (Homo sapiens)	5 / 12	VAL A 231 TYR A 205 TYR A 229 GLY A 208 PRO A 234	None	1.22A	18.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	2qp4	BILE SALT SULFOTRANSFERASE (Homo sapiens)	5 / 12	LEU A  23 TYR A 160 GLY A  10 PHE A   5 LEU A   6	None	1.18A	18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	2vkp	BTB/POZ DOMAIN-CONTAINING PROTEIN 6 (Homo sapiens)	5 / 12	LEU A  66 VAL A  93 TYR A  91 GLY A  33 TYR A  70	None	1.18A	11.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	2zns	GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1 (Homo sapiens)	5 / 12	LEU A 452 VAL A 751 GLY A 750 LEU A 776 TYR A 448	None	1.09A	19.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	3dh1	TRNA-SPECIFIC ADENOSINE DEAMINASE 2 (Homo sapiens)	5 / 12	VAL A  80 VAL A  54 TYR A  50 GLY A  56 PHE A  95	None	1.21A	14.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	3llk	SULFHYDRYL OXIDASE 1 (Homo sapiens)	5 / 12	LEU A 308 VAL A 347 GLY A 343 PHE A 413 LEU A 410	None	1.25A	18.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	3qxm	GLUTAMATE RECEPTOR IONOTROPIC, KAINATE 2 (Homo sapiens)	5 / 12	LEU A 435 VAL A 735 GLY A 734 LEU A 760 TYR A 431	None	1.08A	18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	3thz	DNA MISMATCH REPAIR PROTEIN MSH2 (Homo sapiens)	5 / 12	LEU A 190 VAL A 150 TYR A 165 GLY A 162 PRO A 179	None	1.17A	20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	4e93	TYROSINE-PROTEIN KINASE FES/FPS (Homo sapiens)	5 / 12	LEU A 530 VAL A 482 VAL A 495 LEU A 526 PRO A 524	None	1.12A	22.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	5b16	RIBONUCLEASE 3,DROSHA,RIBONUCLEAS E 3,DROSHA,RIBONUCLEAS E 3 (Homo sapiens)	5 / 12	LEU A1162 PHE A1252 LEU A1249 PRO A1247 TYR A1161	None	1.25A	17.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	5c5b	DCC-INTERACTING PROTEIN 13-ALPHA DCC-INTERACTING PROTEIN 13-BETA (Homo sapiens; Homo sapiens)	5 / 12	LEU A  40 TYR A 203 PHE B  89 LEU B  65 TYR A  36	None	1.26A	20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	5i2c	GATS-LIKE PROTEIN 3 (Homo sapiens)	5 / 12	VAL A  71 PHE A  60 LEU A  63 PRO A  65 TYR A  23	None	1.25A	19.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	5u8q	INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (Homo sapiens)	5 / 12	LEU A  73 GLY A  67 PHE A  45 LEU A  48 PRO A  46	None	1.27A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	5van	BETA-KLOTHO (Homo sapiens)	5 / 12	VAL A 280 TYR A 284 TRP A 236 LEU A 193 TYR A 221	None	1.24A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	5w21	KLOTHO (Homo sapiens)	5 / 12	VAL A 278 TYR A 282 TRP A 234 LEU A 191 TYR A 219	None	1.22A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	6eoq	DIPEPTIDYL PEPTIDASE 9 (Homo sapiens)	5 / 12	LEU A 385 VAL A 403 TYR A 466 LEU A 345 PRO A 341	None	1.10A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	1tvd	T CELL RECEPTOR (Homo sapiens)	5 / 12	VAL A   3 TYR A  36 GLY A 107 PHE A  90 LEU A  33	None	1.36A	12.15 12.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	1xfd	DIPEPTIDYL AMINOPEPTIDASE-LIKE PROTEIN 6 (Homo sapiens)	5 / 12	LEU A 202 VAL A 207 TYR A 244 TYR A 215 GLY A 217	None	1.07A	22.63 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	1xk5	SNURPORTIN-1 (Homo sapiens)	5 / 12	LEU A 115 VAL A 285 VAL A 288 GLY A 287 LEU A 108	None	1.24A	15.72 18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	2b5m	DAMAGE-SPECIFIC DNA BINDING PROTEIN 1 (Homo sapiens)	5 / 12	VAL A 324 VAL A  15 GLY A 325 LEU A 333 GLU A  40	None	1.24A	19.11 18.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	2ch6	N-ACETYL-D-GLUCOSAMI NE KINASE (Homo sapiens)	5 / 12	LEU A  71 VAL A  46 PHE A  95 LEU A  98 TYR A 102	None	1.35A	20.63 21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	2fw2	TESTIS-SPECIFIC CHROMODOMAIN PROTEIN Y 2 (Homo sapiens)	5 / 12	LEU A  19 ASN A 108 VAL A 107 VAL A  60 GLY A 109	None	1.30A	19.29 21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	2qp4	BILE SALT SULFOTRANSFERASE (Homo sapiens)	5 / 12	LEU A  23 TYR A 160 GLY A  10 PHE A   5 LEU A   6	None	1.22A	18.99 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	2vkp	BTB/POZ DOMAIN-CONTAINING PROTEIN 6 (Homo sapiens)	5 / 12	LEU A  66 VAL A  93 TYR A  91 GLY A  33 TYR A  70	None	1.18A	11.61 14.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	3dh1	TRNA-SPECIFIC ADENOSINE DEAMINASE 2 (Homo sapiens)	5 / 12	VAL A  80 VAL A  54 TYR A  50 GLY A  56 PHE A  95	None	1.24A	14.85 17.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	3sei	CASKIN-1 (Homo sapiens)	5 / 12	LEU A  21 ASN A  25 VAL A  49 GLY A  48 LEU A  19	None	1.30A	14.37 16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	3sen	CASKIN-1 (Homo sapiens)	5 / 12	LEU A  24 ASN A  28 VAL A  52 GLY A  51 LEU A  22	None	1.30A	14.52 17.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	4ci8	ECHINODERM MICROTUBULE-ASSOCIAT ED PROTEIN-LIKE 1 (Homo sapiens)	5 / 12	VAL A 787 GLY A 757 PHE A 766 LEU A 765 TYR A 780	None None None None SO4  A1819 (-4.1A)	1.24A	21.86 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	4mtl	PROTEIN-LYSINE METHYLTRANSFERASE METTL21C (Homo sapiens)	5 / 12	LEU A  98 VAL A 195 PHE A 257 LEU A 256 GLU A 118	None SAH  A1001 ( 4.9A) None None UNX  A1016 ( 2.6A)	1.16A	18.18 22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	4ric	FANCONI-ASSOCIATED NUCLEASE 1 (Homo sapiens)	5 / 12	LEU A 845 VAL A 943 GLY A 942 PHE A 838 LEU A 841	None	1.37A	22.52 19.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	5c5b	DCC-INTERACTING PROTEIN 13-ALPHA DCC-INTERACTING PROTEIN 13-BETA (Homo sapiens; Homo sapiens)	5 / 12	LEU A  40 TYR A 203 PHE B  89 LEU B  65 TYR A  36	None	1.33A	20.11 22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	5jtw	COMPLEMENT C4-A (Homo sapiens)	5 / 12	LEU B 931 VAL B 869 VAL B 872 PHE B 899 LEU B 851	None	1.11A	22.03 18.36